Nasdaq: ANIP
ANI Pharmaceuticals insiders
The officers, directors and 10% owners of ANI Pharmaceuticals, Inc. who hold the most stock, valued at the live ANIP price.
$69.13
ANIP today −$2.3M (−3.27%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 11
- Their ANIP stock
- $378M
- Market value
- $1.57B
- Held by ranked insiders
- 24.1%
Insiders by value of ANIP holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Meridian Venture Partners II GP, L.P. | 10% owner | 2,019,259 | $140M | 8.88% | Corporate |
| 2 | Meridian Venture Partners II LP | 10% owner | 1,819,259 | $126M | 8.00% | Corporate |
| 3 | Muthusamy Shanmugam | HEAD OF R&D, COO-NOVITIUM OPS | 537,976 | $37.2M | 2.37% | 3176th |
| 4 | Nikhil Lalwani | PRESIDENT & CEO | 328,289 | $22.7M | 1.44% | 4714th |
| 5 | Chad Gassert | SVP - CORP. DEV. & STRATEGY | 233,406 | $16.1M | 1.03% | 6071st |
| 6 | Stephen P. Carey | SVP & CFO | 166,143 | $11.5M | 0.73% | 7910th |
| 7 | James G. Marken | SVP OPS & PROD DEV | 117,829 | $8.1M | 0.52% | 10253rd |
| 8 | Christopher Mutz | HEAD OF RARE DISEASE | 91,309 | $6.3M | 0.40% | 12326th |
| 9 | Ori Gutwerg | SVP, GENERICS | 75,534 | $5.2M | 0.33% | 14038th |
| 10 | Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | 72,924 | $5.0M | 0.32% | 14375th |
| 11 | Henry O. Gosebruch | Director | 6,662 | $461K | <0.1% | 2475th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for ANI Pharmaceuticals; see each profile for the filing.